dcsimg

It looks like your browser is outdated. For the best experience, please consider updating to the latest version or switching to another browser (Firefox, Chrome, Safari).

Skip Navigation
News release

Baxter Announces DoseEdge Bi-Directional Integration with Epic in the Pharmacy

Printer Friendly Version View printer-friendly version
  • DoseEdge Pharmacy Workflow Manager’s integration with Epic aims to improve pharmacy safety and efficiency*
  • New integration helps hospitals comply with regulatory and insurance requirements

DEERFIELD, Ill.--(BUSINESS WIRE)--Jun. 26, 2017-- Baxter International Inc. (NYSE: BAX), a leader in innovative technology for medication preparation and delivery, announced a new bi-directional integration between the DoseEdge Pharmacy Workflow Manager and the Epic Willow Inpatient Pharmacy System. This integration between the dedicated intravenous (IV) workflow system and the hospital electronic medical record (EMR) can help hospitals efficiently comply with requirements from the Centers for Medicare & Medicaid Services (CMS) and other insurers that call for accuracy in the documentation of the drugs used to compound doses for patients.

“Every time a pharmacist compounds a patient dose of medication in the pharmacy clean room, the DoseEdge System collects data on each ingredient, and can send this information directly to the patient’s medical record, where it can be accessed by the hospital billing system,” said David Ferguson, general manager, Medication Delivery, Baxter. “This integration will help save clinicians time and ensure accuracy, and represents a straightforward way for hospitals to satisfy their pharmacy safety, efficiency and revenue cycle needs.”

The DoseEdge Pharmacy Workflow Manager is an innovative software solution that integrates with hardware used in medication preparation—including barcode scanners, cameras and gravimetric devices that measure final dose weight—to help automate the process of routing, inspecting, tracking and reporting on IV and oral liquid medication doses. With the DoseEdge System, clinicians can conduct preproduction checks to help identify certain common medication preparation errors. Since its inception, the DoseEdge System has processed more than 100 million doses.

Under this new bi-directional integration, inbound medication dose orders are delivered from Epic to the DoseEdge System. Once the dose has been prepared and successfully verified by a pharmacist, the DoseEdge System sends back outbound product usage and wastage data for that dose, including National Drug Code (NDC) numbers and amounts for all source ingredients, amounts required for any overfill requested by the dose order, and amounts wasted from single-use product containers. Having this information also helps improve hospitals’ ability to submit appropriate claims to CMS and other payors, representing a valuable new benefit.

About Baxter

Baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; surgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.

This release includes forward-looking statements concerning Baxter's DoseEdge Pharmacy Workflow Manager, including potential benefits associated with its use. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: safe and proper usage of and functioning between the DoseEdge Pharmacy Workflow Manager and Epic Willow Pharmacy Inpatient Pharmacy System; accuracy and completeness of the new infusion safety data; satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply issues; patient safety issues; breaches or failures of the company’s information technology systems; changes in law and regulations; and other risks identified in Baxter's most recent filing on Form 10-K and other SEC filings, all of which are available on Baxter's website. Baxter does not undertake to update its forward-looking statements.

Baxter and DoseEdge are trademarks of Baxter International Inc.

Epic and Willow are registered trademarks of Epic Systems Corporation.

* The DoseEdge System is not intended to replace the knowledge, judgment or expertise of pharmacists or pharmacy technicians in the preparation of IV admixtures or oral liquid doses. For safe and proper use of this device, refer to the appropriate Users Guide.

Source: Baxter International Inc.

Baxter International Inc.
Media Contact
Eric Tatro, (224) 948-5353
media@baxter.com
or
Investor Contact
Clare Trachtman, (224) 948-3085